Melanoma in situ of other and unspecified parts of face

CD2_INSITU_MELANOMA_FACE

melanoma: A malignant, usually aggressive tumor composed of atypical, neoplastic melanocytes. Most often, melanomas arise in the skin (cutaneous melanomas) and include the following histologic subtypes: superficial spreading melanoma, nodular melanoma, acral lentiginous melanoma, and lentigo maligna melanoma. Cutaneous melanomas may arise from acquired or congenital melanocytic or dysplastic nevi. Melanomas may also arise in other anatomic sites including the gastrointestinal system, eye, urinary tract, and reproductive system. Melanomas frequently metastasize to lymph nodes, liver, lungs, and brain.

Endpoint definition

FinnGen phenotype data

356077 individuals

diagram downward connector

Apply sex-specific rule None

356077

diagram downward connector

Check conditions None

356077

diagram downward connector
diagram bullet

Filter registries

Hospital Discharge: ICD-10 D03.30&, D03.31&
Hospital discharge: ICD-9 $!$
Hospital discharge: ICD-8 $!$
Cause of death: ICD-10 D03.30&, D03.31&
Cause of death: ICD-9 $!$
Cause of death: ICD-8 $!$

226

diagram downward connector
diagram bullet

Check pre-conditions, main-only, mode, ICD version

Look only at ICD versions H.D: 10, 8, 9 ; C.O.D: 10, 8, 9

226

diagram downward connector

Check minimum number of events None

226

diagram downward connector

Include endpoints None

226

diagram downward connector
CD2_INSITU_MELANOMA_FACE

Extra metadata

Level in the ICD hierarchy 3
First used in FinnGen datafreeze DF2

Summary Statistics

Key figures

All Female Male
Number of individuals 226 106 120
Unadjusted prevalence (%) 0.06 0.05 0.08
Mean age at first event (years) 71.93 69.55 74.02

Mortality

Follow-up Absolute risk HR [95% CI] p N
1998–2019 - - - -
15 years - - - -
5 years - - - -
1 year - - - -

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Correlations

Index endpoint: CD2_INSITU_MELANOMA_FACE – Melanoma in situ of other and unspecified parts of face
GWS hits:

Survival analyses between endpoints

Plot

before Melanoma in situ of other and unspecified parts of face
after Melanoma in situ of other and unspecified parts of face

loading spinner Loading survival analyses plot

Drugs most likely to be purchased after Melanoma in situ of other and unspecified parts of face